Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 1, 1998.
Copyright & Usage
Copyright © American Society of Neuroradiology
Author Information
Altmetrics
Cited By...
In this issue
Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.
Jump to section
Related Articles
Cited By...
- Hypertensive brainstem encephalopathy: a diagnosis often overlooked
- Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab in Breast Cancer
- Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma
- Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation
- Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome
- Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome
- Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
- Blindness in a case of tetanus.
- Pretransplantation Conditioning Influence on the Occurrence of Cyclosporine or FK-506 Neurotoxicity in Allogeneic Bone Marrow Transplantation
- Posterior Reversible Encephalopathy Syndrome: Prognostic Utility of Quantitative Diffusion-Weighted MR Images
- Diffuse Metabolic Abnormalities in Reversible Posterior Leukoencephalopathy Syndrome
- Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors
- Etiology of Cortical and White Matter Lesions in Cyclosporin-A and FK-506 Neurotoxicity
- Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis
- Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia
- Reversible Tacrolimus-induced Neurotoxicity Isolated to the Brain Stem